ACAD Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: ACAD Market Cap History ACAD YTD Return |
ACAD Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: ACAD Market Cap History ACAD YTD Return |
ACAD Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+10.31% CAGR ![]() Mouse over chart for data details
|
ACAD Stock Price Chart |
About Acadia Pharmaceuticals Inc |
Acadia Pharmaceuticals Inc. is a biopharmaceutical company. Co. is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders and rare diseases. Its pipeline includes NUPLAZID (pimavanserin), DAYBUE (trofinetide), ACP-101, ACP-204, and Antisense Oligonucleotide (ASO) Programs. NUPLAZID is a selective serotonin inverse agonist/antagonist preferentially targeting the 5-HT2A receptor. We show 61 historical shares outstanding datapoints in our coverage of ACAD's shares outstanding history. Understanding the changing numbers of ACAD shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ACAD versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ACAD by allowing them to research ACAD shares outstanding history as well as any other stock in our coverage universe. |
ACAD Current Stock Quote |
![]() Get Dividend Alerts ![]() Get SEC Filing Alerts ![]() |
Video: Shares Outstanding Importance | |
|
ACAD Share Performance |
Shares Outstanding Peers |
Acadia Pharmaceuticals (ACAD) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ACCD Shares Outstanding History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.